Dual Targeting of the Epidermal Growth Factor Receptor...

Journal of Clinical Oncology 2012 / 05 Vol. 30; Iss. 13

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

Weickhardt, A. J., Price, T. J., Chong, G., Gebski, V., Pavlakis, N., Johns, T. G., Azad, A., Skrinos, E., Fluck, K., Dobrovic, A., Salemi, R., Scott, A. M., Mariadason, J. M., Tebbutt, N. C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.38.6599
Date:
May, 2012
File:
PDF, 240 KB
english, 2012
Conversion to is in progress
Conversion to is failed